Bioactive Coating Technologies for PTFE Artificial Vascular Grafts

Although PTFE artificial vascular grafts have excellent mechanical stability and biosafety, their inherent super-hydrophobic and chemically inert surface cannot actively interact with biological tissues and blood components, resulting in slow endothelialization and easy thrombosis after long-term implantation. Bioactive coating technology is one of the most effective and mature functional modification methods for PTFE vascular grafts, which constructs a bioactive functional layer on the inert PTFE surface by loading biological active factors, realizing active anticoagulation, rapid endothelialization, anti-inflammation and antibacterial functions. This technology perfectly retains the excellent mechanical properties of PTFE substrates while endowing vascular grafts with active biological regulation ability, greatly improving the clinical patency rate and application value of PTFE vascular prosthetics PTFE SHEET.

Bioactive coating technologies for PTFE vascular grafts are mainly divided into single-functional coating and composite multi-functional coating systems, including anticoagulant coatings, cell-adhesive coatings, growth factor loaded coatings, antibacterial coatings and intelligent responsive coatings. Anticoagulant bioactive coatings represented by heparin coatings are the earliest and most widely used functional coatings. Heparin molecules are stably immobilized on the PTFE surface through covalent bonding or electrostatic adsorption, which can continuously inhibit the activity of coagulation factors in blood, prevent platelet aggregation and adhesion, and effectively reduce the risk of acute and subacute thrombosis after graft implantation. Compared with uncoated PTFE grafts, heparin-coated vascular grafts have a significantly lower early thrombosis rate and better intraoperative and postoperative safety.

Endothelialization bioactive coatings focus on promoting rapid endothelial cell adhesion, proliferation and coverage to form a natural anti-thrombotic endothelial barrier. Common coating materials include collagen, gelatin, fibronectin and polypeptide bioactive coatings. These natural biological macromolecules can simulate the extracellular matrix microenvironment of natural vascular intima, provide good growth carriers for endothelial progenitor cells and vascular endothelial cells, and accelerate the formation of complete endothelial layer on the graft surface. Once the endothelialization is completed, the synthetic graft surface is transformed into biological vascular intima, which fundamentally solves the problem of thrombosis and intimal hyperplasia. Precision coating technology ensures that the bioactive layer is uniformly distributed on the inner wall of PTFE TUBE vascular grafts, avoiding local functional deficiency.

Growth factor loaded bioactive coatings realize intelligent regulation of vascular tissue regeneration by loading vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and other active factors. Different from passive cell adhesion coatings, growth factor coatings can actively recruit circulating endothelial progenitor cells in blood, induce directional proliferation and differentiation of endothelial cells, and greatly shorten the endothelialization cycle of PTFE vascular grafts. In order to solve the problem of rapid burst release of growth factors, modern controlled-release coating technologies adopt microcapsule embedding and multilayer slow-release structures, realizing long-term stable release of active factors and maintaining persistent endothelialization promotion function.

Multi-functional composite bioactive coatings have become the mainstream development direction of current coating technology. This composite coating integrates anticoagulation, anti-inflammation, antibacterial and endothelialization promotion functions, solving multiple clinical pain points simultaneously. For example, heparin-chitosan composite coatings not only have excellent anticoagulant performance, but also inhibit bacterial adhesion and inflammatory cell infiltration, effectively preventing postoperative graft infection and chronic inflammatory stenosis. The polydopamine-based universal bioactive coating has strong adhesion and excellent biocompatibility, which can stably bind multiple active molecules and realize multi-functional integration modification on PTFE surface.

With the continuous innovation of bioactive coating technology, intelligent responsive coatings are gradually applied to PTFE vascular graft modification. pH-responsive, temperature-responsive and enzyme-responsive coatings can intelligently adjust the release rate of active factors according to the changes of in-vivo microenvironment, realizing targeted treatment of thrombosis, inflammation and other adverse reactions. Bioactive coating technology continues to bridge the biological performance gap between PTFE synthetic grafts and autologous blood vessels, providing strong technical support for the long-term stable operation of artificial vascular grafts in clinical vascular reconstruction.